{"transactions":[{"id":941771,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-09T21:08:11.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":1655949,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2026, the final 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":8591093,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1655949},"source":{"system":"sec-edgar","filing":"0001801170-26-000013","document":"wk-form4_1767992888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000013/wk-form4_1767992888.xml","form_type":"4"}},{"id":941770,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-09T21:08:11.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":3342699,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2026, the final 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":10247042,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3342699},"source":{"system":"sec-edgar","filing":"0001801170-26-000013","document":"wk-form4_1767992888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000013/wk-form4_1767992888.xml","form_type":"4"}},{"id":941769,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-09T21:08:11.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":3342699,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3342699},"source":{"system":"sec-edgar","filing":"0001801170-26-000013","document":"wk-form4_1767992888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000013/wk-form4_1767992888.xml","form_type":"4"}},{"id":941768,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-09T21:08:11.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1655949,"price":2.59,"value":4288907.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2026, the final 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."}],"balance_after":1856247,"source":{"system":"sec-edgar","filing":"0001801170-26-000013","document":"wk-form4_1767992888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000013/wk-form4_1767992888.xml","form_type":"4"}},{"id":941767,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-09T21:08:11.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":1655949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2026, the final 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":3512196,"source":{"system":"sec-edgar","filing":"0001801170-26-000013","document":"wk-form4_1767992888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000013/wk-form4_1767992888.xml","form_type":"4"}},{"id":1071029,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-08T20:07:07.000Z","date":"2025-08-08","kind":"purchase","planned":false,"acquired":true,"shares":31980,"price":2.17,"value":69396.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.15 to $2.21, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 2 to this Form 4."}],"balance_after":1856247,"source":{"system":"sec-edgar","filing":"0001801170-25-000207","document":"wk-form4_1754683623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000207/wk-form4_1754683623.xml","form_type":"4"}},{"id":1071028,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-08T20:07:07.000Z","date":"2025-08-07","kind":"purchase","planned":false,"acquired":true,"shares":415000,"price":2.24,"value":929600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.16 to $2.32, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":1824267,"source":{"system":"sec-edgar","filing":"0001801170-25-000207","document":"wk-form4_1754683623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000207/wk-form4_1754683623.xml","form_type":"4"}},{"id":1304830,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2025-01-10T21:34:00.000Z","date":"2025-01-07","kind":"exercise","planned":false,"acquired":false,"shares":1670965,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2025, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":6904343,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1670965},"source":{"system":"sec-edgar","filing":"0001801170-25-000027","document":"wk-form4_1736544833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000027/wk-form4_1736544833.xml","form_type":"4"}},{"id":1304829,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2025-01-10T21:34:00.000Z","date":"2025-01-07","kind":"exercise","planned":false,"acquired":true,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2025, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":8575308,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0001801170-25-000027","document":"wk-form4_1736544833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000027/wk-form4_1736544833.xml","form_type":"4"}},{"id":1304828,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-01-10T21:34:00.000Z","date":"2025-01-07","kind":"exercise","planned":false,"acquired":false,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."}],"balance_after":3342699,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0001801170-25-000027","document":"wk-form4_1736544833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000027/wk-form4_1736544833.xml","form_type":"4"}},{"id":1304827,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-10T21:34:00.000Z","date":"2025-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1670965,"price":3.6,"value":6015474.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2025, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."}],"balance_after":1409267,"source":{"system":"sec-edgar","filing":"0001801170-25-000027","document":"wk-form4_1736544833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000027/wk-form4_1736544833.xml","form_type":"4"}},{"id":1304826,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-10T21:34:00.000Z","date":"2025-01-07","kind":"exercise","planned":false,"acquired":true,"shares":1670965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2025, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":3080232,"source":{"system":"sec-edgar","filing":"0001801170-25-000027","document":"wk-form4_1736544833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000027/wk-form4_1736544833.xml","form_type":"4"}},{"id":1434451,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-13T20:06:53.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":531700,"price":1.88,"value":999596.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.84 to $1.91, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":1409267,"source":{"system":"sec-edgar","filing":"0001801170-24-000172","document":"wk-form4_1723579605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000172/wk-form4_1723579605.xml","form_type":"4"}},{"id":1472704,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-20T20:03:32.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":877567,"price":1.14,"value":1000426.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.08 to $1.17, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":877567,"source":{"system":"sec-edgar","filing":"0001801170-24-000132","document":"wk-form4_1718913804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000132/wk-form4_1718913804.xml","form_type":"4"}},{"id":1682203,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2024-01-09T21:05:08.000Z","date":"2024-01-07","kind":"exercise","planned":false,"acquired":false,"shares":1561065,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2024, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":5232610,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1561065},"source":{"system":"sec-edgar","filing":"0001801170-24-000039","document":"wk-form4_1704834283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000039/wk-form4_1704834283.xml","form_type":"4"}},{"id":1682202,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2024-01-09T21:05:08.000Z","date":"2024-01-07","kind":"exercise","planned":false,"acquired":true,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2024, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":6793675,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0001801170-24-000039","document":"wk-form4_1704834283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000039/wk-form4_1704834283.xml","form_type":"4"}},{"id":1682201,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-01-09T21:05:08.000Z","date":"2024-01-07","kind":"exercise","planned":false,"acquired":false,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."}],"balance_after":6685397,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0001801170-24-000039","document":"wk-form4_1704834283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000039/wk-form4_1704834283.xml","form_type":"4"}},{"id":1682200,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-09T21:05:08.000Z","date":"2024-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1561065,"price":0.95,"value":1483011.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2024, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001801170-24-000039","document":"wk-form4_1704834283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000039/wk-form4_1704834283.xml","form_type":"4"}},{"id":1682199,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-09T21:05:08.000Z","date":"2024-01-07","kind":"exercise","planned":false,"acquired":true,"shares":1561065,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2024, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,781,633 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,561,065 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":1561065,"source":{"system":"sec-edgar","filing":"0001801170-24-000039","document":"wk-form4_1704834283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000039/wk-form4_1704834283.xml","form_type":"4"}},{"id":1911123,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairperson"}}],"security":"Class B Common Stock","published_at":"2023-04-29T00:23:10.000Z","date":"2023-01-07","kind":"exercise","planned":false,"acquired":false,"shares":1569594,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2023, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":3450977,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1569594},"source":{"system":"sec-edgar","filing":"0000895345-23-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000261/form4.xml","form_type":"4"}},{"id":1911122,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairperson"}}],"security":"Class B Common Stock","published_at":"2023-04-29T00:23:10.000Z","date":"2023-01-07","kind":"exercise","planned":false,"acquired":true,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 7, 2023, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":5020571,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0000895345-23-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000261/form4.xml","form_type":"4"}},{"id":1911121,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairperson"}}],"security":"Restricted Stock Unit","published_at":"2023-04-29T00:23:10.000Z","date":"2023-01-07","kind":"exercise","planned":false,"acquired":false,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021."}],"balance_after":10028095,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0000895345-23-000261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000261/form4.xml","form_type":"4"}},{"id":1911120,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairperson"}}],"security":"Class A Common Stock","published_at":"2023-04-29T00:23:10.000Z","date":"2023-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1569594,"price":1.01,"value":1585289.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2023, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-23-000261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000261/form4.xml","form_type":"4"}},{"id":1911119,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairperson"}}],"security":"Class A Common Stock","published_at":"2023-04-29T00:23:10.000Z","date":"2023-01-07","kind":"exercise","planned":false,"acquired":true,"shares":1569594,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 7, 2023, 20% of the original number of restricted stock units (\"RSUs\") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer."}],"balance_after":1569594,"source":{"system":"sec-edgar","filing":"0000895345-23-000261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000261/form4.xml","form_type":"4"}},{"id":2437324,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-01-12T02:51:43.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":3342698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 7, 2021, the Reporting Person was granted 16,713,491 RSUs, vesting in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 7, 2021, the Reporting Person was granted 16,713,491 RSUs, vesting in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer."}],"balance_after":13370793,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3342698},"source":{"system":"sec-edgar","filing":"0001628280-22-000730","document":"wf-form4_164195588944291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022000730/wf-form4_164195588944291.xml","form_type":"4"}},{"id":2437323,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2022-01-12T02:51:43.000Z","date":"2022-01-07","kind":"tax_withholding","acquired":false,"shares":1664825,"price":3.16,"value":5260847.0,"ownership":{"direct":true},"balance_after":1677873,"source":{"system":"sec-edgar","filing":"0001628280-22-000730","document":"wf-form4_164195588944291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022000730/wf-form4_164195588944291.xml","form_type":"4"}},{"id":2437322,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2022-01-12T02:51:43.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":3342698,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration."}],"balance_after":3342698,"source":{"system":"sec-edgar","filing":"0001628280-22-000730","document":"wf-form4_164195588944291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000162828022000730/wf-form4_164195588944291.xml","form_type":"4"}},{"id":2910396,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":5571164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."}],"balance_after":5571164,"derivative":{"underlying":"Class B Common Stock","underlying_shares":5571164},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910395,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":16713491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The RSUs will vest in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date.  Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The RSUs will vest in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date.  Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."}],"balance_after":16713491,"derivative":{"underlying":"Class B Common Stock","underlying_shares":16713491},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910394,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":7164581,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in connection with the Business Combination in exchange for restricted stock units that will have settled for 3,464,373 shares of common stock of Legacy Clover."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each performance-based restricted stock unit (\"PRSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock. The PRSUs generally vest in five equal installments on January 7 of each of 2022, 2023, 2024, 2025 and 2026 respectively, provided that the applicable performance goal has been achieved by such date (and, if not, on the date the applicable performance goal is subsequently achieved), and are subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through the applicable vesting date. The applicable performance goal for each tranche will be satisfied if the Issuer's Class A Common Stock achieves a specified per share market price for such tranche for at least 90 consecutive calendar days. If the applicable performance goals have not been achieved by January 7, 2026, all unvested PRSUs will be forfeited."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."}],"balance_after":7164581,"derivative":{"underlying":"Class B Common Stock","underlying_shares":7164581},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910393,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":2062265,"ownership":{"direct":false,"nature":"Held by Caesar Clover, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in connection with the Business Combination in exchange for 997,191 shares of Class Z common stock of Legacy Clover."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC. Therefore, the Reporting Person may be deemed to share voting power and dispositive power over the shares held by these entities."}],"balance_after":2062265,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2062265},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910392,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":5645934,"ownership":{"direct":false,"nature":"Held by Caesar Ventures, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Business Combination in exchange for 2,730,044 shares of Class Z common stock of Legacy Clover."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC. Therefore, the Reporting Person may be deemed to share voting power and dispositive power over the shares held by these entities."}],"balance_after":5645934,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5645934},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910391,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":182201,"ownership":{"direct":false,"nature":"Held by Titus Ventures, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in connection with the Business Combination in exchange for 88,102 shares of Class Z common stock of Legacy Clover."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC. Therefore, the Reporting Person may be deemed to share voting power and dispositive power over the shares held by these entities."}],"balance_after":182201,"derivative":{"underlying":"Class A Common Stock","underlying_shares":182201},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}},{"id":2910390,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":69614,"kind":"person","name":"Garipalli Vivek","position":1,"cik":"0001839260","reported_name":"Garipalli Vivek","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2021-01-12T02:14:13.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":75694143,"ownership":{"direct":false,"nature":"Held by NJ Healthcare Investments, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in connection with the Issuer's business combination (the \"Business Combination\") with Clover Health Investments, Corp. (\"Legacy Clover\") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 36,601,265 shares of Class Z common stock of Legacy Clover."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer.  In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC. Therefore, the Reporting Person may be deemed to share voting power and dispositive power over the shares held by these entities."}],"balance_after":75694143,"derivative":{"underlying":"Class A Common Stock","underlying_shares":75694143},"source":{"system":"sec-edgar","filing":"0001209191-21-003159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000120919121003159/doc4.xml","form_type":"4"}}]}